Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05044429 · ClinicalTrials.gov registry record · Phase 4
Postoperative Pain Control Following Renal Transplant
A Phase 4 study, sponsored by George Washington University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT05044429: Clinical Trial Phase 4 study, sponsored by George Washington University.
NCT05044429 is a Phase 4 study that was terminated before completion, run by George Washington University. The registered enrollment target is 31 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05044429, a Phase 4 study, was terminated before completion, sponsored by George Washington University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study aims to compare the effectiveness of a regional anesthetic block vs systemic intravenous (IV) lidocaine in controlling post-operative pain in kidney transplantation patients. Regional anesthetic blocks and lidocaine infusions are effective alternatives to opioid medications and are already in use at many institutions. However, there has been no prospective study comparing their effectiveness when used in conjunction with the current standard of care patient controlled analgesia (PCA) pumps. This study is a prospective, randomized evaluation of both treatment methods.
Primary Outcome
We are measuring oral morphine equivalents to assess for study intervention efficacy at 12 hours after surgery
Interventions
- DRUG Intravenous Lidocaine
- DRUG Transversus abdominis plane (TAP) block
- DRUG Quadratus Lumborum (QL) Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2021-03-16 |
| Est. Completion | 2023-11-29 |
| Phase | Phase 4 |
Why NCT05044429 stopped before completion
NCT05044429 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Intravenous Lidocaine is the first listed.
NCT05044429 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05044429 about?
NCT05044429 is a clinical study titled "Postoperative Pain Control Following Renal Transplant". This study aims to compare the effectiveness of a regional anesthetic block vs systemic intravenous (IV) lidocaine in controlling post-operative pain in kidney transplantation patients. Regional anesthetic blocks and lidocaine infusions are effective alternatives to opioid medications and are alread...
What is the current status of trial NCT05044429?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2021-03-16. Estimated completion is 2023-11-29.
What interventions are being tested in trial NCT05044429?
The interventions under investigation include: Intravenous Lidocaine (DRUG), Transversus abdominis plane (TAP) block (DRUG), Quadratus Lumborum (QL) Block (DRUG).
Who is sponsoring clinical trial NCT05044429?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05044429's enrollment target sits among peer trials
31 1544th of 2000 higher than 449 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI